Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with few treatment options. Since 2018, the Sean M.
Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...
Former bodybuilder Tony McCue began stumbling and 'dropping things' two years ago. After being diagnosed with locked-in ...
Patients increasingly complain that it is difficult to win approval from health insurance companies for certain types of ...
3d
News Medical on MSNFirst insights into genotype and phenotype of familial amyotrophic lateral sclerosis in Egypt: early onset and high consanguinityAmyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by the progressive degeneration of motor neurons, leading to muscle weakness and eventually death. While ...
4d
Medpage Today on MSNTwo Investigational Treatments for ALS Show Glimmer of HopeThe first four treatments in a platform trial for amyotrophic lateral sclerosis (ALS) failed to reach key endpoints in phase ...
19h
News Medical on MSNExploring how 25-hydroxycholesterol triggers ferroptosis in glial cellsOxysterols are a class of molecules derived from cholesterol via oxidation or as byproducts of cholesterol synthesis.
NEW YORK, NY / ACCESS Newswire / February 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Voyager ...
ALS is a progressive neurodegenerative disease that currently has no cure. Commonly known as Lou Gehrig’s disease, ALS ...
Scientists have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection, a challenge that has long been limited by the protective nature ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results